Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1785-1787

  Kobak, Senol ^a,b  

^a Manisa Hospital   (Turkey)

^b Manisa Devlet Hastanesi   (Turkey)

Author keywords

Adalimumab; Ankylosing spondylitis; Peritoneal dialysis

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; ISONIAZID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; SALAZOSULFAPYRIDINE; SERUM ALBUMIN; UREA;

ABSENCE OF SIDE EFFECTS; AGED; ANEMIA; ANKYLOSING SPONDYLITIS; ARTICLE; BACKACHE; CASE REPORT; CHRONIC KIDNEY FAILURE; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MALE; MUSCULOSKELETAL STIFFNESS; PANCYTOPENIA; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; PATIENT SAFETY; PERITONEAL DIALYSIS; RISK ASSESSMENT; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863862501     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1457-7     Document Type: Article

References (12)

1. Hazenberg BP, van Rijswijk MH (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8:661-690
2. Aronoff GR, Brier M (2004) Prescribing drugs in renal disease. In: Brenner BM (ed) Brenner and Rector's the kidney, vol 2, 7th edn. Saunders, Philadelphia, pp 2850-2870
3. Don BR, Spin G, Nestorov I et al (2005) The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol 57:1407-1413
4. Sugioka Y, Inui K, Koike T (2008) Use of etanercept in a patient with rheumatoid arthritis on hemodialysis. Mod Rheumatol 18:293-295
5. Cassano N, Vena GA (2008) Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection. Int J Dermatol 47:970-971
6. Hammoudeh M (2006) Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology (Oxford) 45:357-359
7. Yee AM, Pochapin MB (2001) Treatment of sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27-31
8. Ortiz-Santamaria V, Valls-Roc M, Sanmari M et al (2003) Anti-TNF treatment in secondary amyloidosis. Rheumatology 42:1425-1426
9. Singh R, Cuchacovich R, Huang W et al (2002) Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 29:636-637
10. Nakamura M, Sakemi T, Nagasawa K (1999) Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis. J Rheumatol 26:1424-1425
11. Boulanger H, Launay-Vacher V, Hierniaux P, Fau JB, Deray G (2001) Severe methotrexate intoxication in a hemodialysis patient treated for rheumatoid arthritis. Nephrol Dial Transplant 16:1087
12. Akiyama Y, Fujimaki T, Sakurai Y (2003) Pharmacokinetics of salazosulfapyridine in a hemodialysis patient (in Japanese). Ryumachi 43:569-576